“…These periodic oscillations, or skin flowmotion, represent the influence of heart beat (0.6–2.0Hz), respiration (0.15–0.6Hz), myogenic (~0.05–0.15Hz) (Stefanovska et al, 1999), neurogenic (~0.02–0.05Hz) (Kastrup et al, 1989; Soderstrom et al, 2003), and endothelial (~0.0095–0.02Hz) influences on vascular smooth muscle relaxation (Gustafsson et al, 1993; Kvandal et al, 2003; Kvernmo et al, 1999; Rossi et al, 2008a). Spectral analysis has been performed on populations with known microvascular dysfunction such as peripheral arterial obstructive disease (Rossi et al, 2005), chronic kidney disease (Rossi et al, 2008b), diabetes (Schmiedel et al, 2007), chronic smokers (Avery et al, 2009; Rossi et al, 2007), hypercholesterolemics (Rossi et al, 2009) and essential hypertensive men and women (Gryglewska et al, 2010a; Gryglewska et al, 2010b; Rossi et al, 2006). While these studies observed altered skin flowmotion responses, many of them utilized different skin vasoreactivity tests and subject populations in which the mechanisms mediating skin blood flow are not thoroughly understood.…”